Re: Valneva vaccine
Posted 7/22/2021 9:14:45 PM by GoldenRod
https://valneva.com/research-development/covid-19-vla2001/
What is VLA2001 and how is it different from other approaches? VLA2001 is a Vero-cell based, highly-purified inactivated whole virus vaccine candidate. VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe. The inactivated vaccine is a proven approach that has been used for decades. [1] An inactivated SARS-CoV-2 vaccine is expected to be suitable for wide deployment. Valneva’s vaccine candidate is based on the same manufacturing platform the Company already uses to produce its FDA/EMA/MHRA approved JE vaccine. VLA2001 combined with alum and Dynavax’s adjuvant CpG 1018 has been demonstrated in preclinical studies and as confirmed by recently obtained initial Phase 1/2 clinical data to induce a strong immune response and has the potential to generate high titers of neutralizing antibodies. Valneva’s inactivated SARS-CoV-2 vaccine is expected to have a two-dose regimen. VLA2001 is expected to conform with standard cold chain requirements (2 degrees to 8 degrees centigrade).
|